Inhibition of Molecular Pathway Lets Mouse Blastocysts Survive for Weeks in the Lab
UC San Francisco researchers have found a way to pause the development of early mouse embryos for up to a month in the lab, a finding with potential implications for assisted reproduction, regenerative medicine, aging and even cancer, the authors say.
The new study — published online Nov. 23, 2016, in Nature – involved experiments with pre-implantation mouse embryos, called blastocysts. The researchers found that drugs that inhibit the activity a master regulator of cell growth called mTOR can put these early embryos into a stable and reversible state of suspended animation.
“Normally, blastocysts only last a day or two, max, in the lab. But blastocysts treated with mTOR inhibitors could survive up to four weeks,” said the study’s lead author, Aydan Bulut-Karslioglu, PhD, a postdoctoral researcher in the lab of senior author Miguel Ramalho-Santos, PhD, who is an associate professor of obstetrics/gynecology and reproductive sciences at UCSF.
Bulut-Karslioglu and colleagues showed that paused embryos could quickly resume normal growth when mTOR inhibiters were removed, and developed into healthy mice if implanted back into a recipient mother.
Discovery was Surprise to Researchers
The discovery was a surprise to the researchers, who had intended to study how mTOR-inhibiting drugs slow cell growth in blastocysts, not to find a way to put the embryos into hibernation.
“It was completely surprising. We were standing around in the tissue culture room, scratching our heads, and saying wow, what do we make of this?” said Ramalho-Santos, who is a member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research. “To put it in perspective, mouse pregnancies only last about 20 days, so the 30-day-old ‘paused’ embryos we were seeing would have been pups approaching weaning already if they’d been allowed to develop normally.”
Further experiments demonstrated that cultured mouse embryonic stem cells – which are derived from the blastocyst-stage embryo – can also be put into suspended animation by mTOR inhibitors. The drugs appear to act by reducing gene activity across much of the genome, the team found, with the exception of a handful of so-called “repressor” genes that themselves may act to inhibit gene activity. The researchers tested a number of different mTOR inhibitors and found that the most effective was a new synthetic drug called Rapa-Link that was recently developed at UCSF by the lab of Kevan Shokat, PhD.
The researchers believe that it should be possible to extend the suspended animation for much longer than the 30 days observed in the present study, Bulut-Karslioglu said: “Our dormant blastocysts are eventually dying when they run out of some essential metabolite within them. If we could supply those limiting nutrients in the culture medium, we should be able to sustain them even longer. We just don’t know exactly what they need yet.”
Drug-Induced Dormancy Mimics Natural Pausing
Bulut-Karslioglu and colleagues demonstrated that the dormant state they were able to induce in blastocysts by blocking mTOR was almost identical to the natural ability of mice to pause a pregnancy in its early stages. This temporary stasis, called diapause, occurs in species across the animal kingdom, and in mammals from mice to wallabies, it typically allows mothers to delay pregnancy when food is scarce or they are otherwise stressed.
It makes sense that mTOR would be involved in the process of diapause, Ramalho-Santos said: “mTOR is this beautiful regulator of developmental timing that works by being a nutrient sensor. It doesn’t just drive cells into growing willy-nilly; it tunes cell growth based on the level of nutrients that are available in the environment.”
It is an open question whether humans also have the ability to pause pregnancies at the blastocyst stage, Bulut-Karslioglu said, because the time from fertilization to implantation is hard to measure in humans. However, anecdotal accounts from practitioners of in vitro fertilization of unusually long pregnancies and mismatches between the timing of artificial embryo transfer and the resulting pregnancy suggest that humans too may have the ability to delay implantation of fertilized embryos in some circumstances.
Implications for Other Fields of Medicine
The new research could have a big impact on the field of assisted reproduction, where practitioners are currently limited by the rapid degradation of embryos once they reach the blastocyst stage. Putting blastocysts into suspended animation may avoid the compromise of freezing embryos and give practitioners more time to test fertilized blastocysts for genetic defects before implanting them, Bulut-Karslioglu said.
MTOR inhibitors are already in clinical trials to treat certain forms of cancer, but the new results suggest a potential danger of this approach, Ramalho-Santos said: “Our results suggest that mTOR inhibitors may well slow cancer growth and shrink tumors, but could leave behind these dormant cancer stem cells that could go back to spreading after therapy is interrupted. You might use a second or third line of drugs specifically to kill off those remaining dormant cells.”
The authors are eager to explore whether mTOR inhibitors and related downstream biochemical pathways can drive stem cells into a dormant state at later stages of development, which could have major implications efforts to repair or replace ailing organs in the field of regenerative medicine. The findings also have potential implications in aging research, the authors say, where mTOR inhibitors have already been shown to extend the lives of mice and other animals, an outcome which the authors suggest could result in part from preserving more youthful stem cells.
“This is a great example of the power of basic science,” Ramalho-Santos said. “We weren’t looking for ways to pause blastocyst development or mimic diapause. We weren’t trying to model aging or test cancer therapies or develop better techniques for tissue regeneration or organ transplantation. None of that was in our mind, but our experiments told us we were on to something we had to understand, and we couldn’t ignore where they led.”
The Latest on: Suspended animation
via Google News
The Latest on: Suspended animation
- Humans put into suspended animation for first timeon November 26, 2019 at 1:42 am
Doctors have put humans into a state of suspended animation for the first time in a groundbreaking trial that aims to buy more time for surgeons to save seriously injured patients. The process ...
- Humans put in ‘suspended animation’ for first timeon November 25, 2019 at 7:37 pm
US doctors have placed live human patients in suspended animation for the first time, in trials designed to allow surgeons greater opportunity to carry out life-saving operations. “At least one ...
- ‘Suspended Animation’: Can Cooling Our Bodies To Super Low Temperatures Save Us After Deadly Trauma And Blood Loss?on November 25, 2019 at 9:06 am
This induced state of hypothermia effectively places the body into a state of suspended animation, almost a type of “standby mode”. In this state, the body’s metabolism drastically decreases, and our ...
- Hacking Surgery: Suspended Animation May Be Hereon November 23, 2019 at 7:18 pm
Suspended animation is a staple of science fiction. Need to take a 200 year trip to another star system? Go to sleep in some sort of high-tech coccoon and wake up at your destination. We saw it in ...
- Doctors Put a Patient in Suspended Animation for the First Timeon November 22, 2019 at 8:06 pm
For the first time, scientists have used therapeutic suspended animation to purposefully induce hypothermia and slow organ functions in patients with traumatic injuries, such as gunshot and stab ...
- So, WTF Is Up With Putting a Human in ‘Suspended Animation?’on November 22, 2019 at 11:13 am
At least one patient has been treated with an experimental therapy that rapidly lowers their body temperature to a state of suspended animation, the trial's leader revealed to New Scientist this week.
- Suspended animation induced in humans for the first timeon November 21, 2019 at 7:08 pm
Surgeons in the operating room. Researchers at the University of Maryland believe rapidly cooling the body could put patients into a state of suspended animation. A team of surgeons at the University ...
- Humans put in suspended animation – here's everything you need to knowon November 21, 2019 at 9:36 am
Yesterday, New Scientist broke the news that suspended animation has been tried on humans for the first time. The idea is to buy doctors more time to operate on people who would otherwise die from ...
- Doctors Place Humans in True Suspended Animation for First Timeon November 20, 2019 at 11:03 am
New Scientist reports that doctors have used therapeutic suspended animation for the first time as part of a carefully designed human trial. The procedure, called E (EPR), is a way to try to save the ...
via Bing News